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Due to their chemical versatility, transition metals were incorporated as cofactors for
several basic metabolic pathways in living organisms. This same characteristic makes
them potentially harmful, since they can be engaged in deleterious reactions like Fenton
chemistry. As such, organisms have evolved highly specialized mechanisms to supply their
own metal needs while keeping their toxic potential in check. This dual character comes
into play in host-pathogen interactions, given that the host can either deprive the pathogen
of these key nutrients or exploit them to induce toxicity toward the invading agent.
Iron stands as the prototypic example of how a metal can be used to limit the growth
of pathogens by nutrient deprivation, a mechanism widely studied in Mycobacterium
infections. However, the host can also take advantage of iron-induced toxicity to control
pathogen proliferation, as observed in infections caused by Leishmania. Whether we
may harness either of the two pathways for therapeutical purposes is still ill-defined.
In this review, we discuss how modulation of the host iron availability impacts the
course of infections, focusing on those caused by two relevant intracellular pathogens,
Mycobacterium and Leishmania.
Keywords: transition metal, immunity, Mycobacterium, Leishmania, infection
IRON IN BIOLOGIC SYSTEMS AND INFECTION PROCESSES
Transitionmetals are elements that have an incomplete inner elec-
tron shell and can easily shift between different oxidation states.
Cells took advantage of this property and included transition
metals into proteins, gaining catalytic potential and protein sta-
bility. The function of transition metals in enzymatic catalysis
can be divided into two groups, depending upon the metal act-
ing as a redox center or not. Of the redox active metals, iron is
the most prevalent, followed by copper and molybdenum, while
zinc is the most common non-redox transition metal (Andreini
et al., 2008). Iron is found in an unparalleled variety of sites and
cofactors, such as haem groups and iron-sulphur clusters, and
is involved in processes such as oxygen sensing and transport,
energy metabolism and nucleic acid synthesis. The predominance
of iron is presumably due to the large availability of water soluble
ferrous iron during prebiotic times, before the rise of atmospheric
oxygen levels caused by photosynthesis resulted in the precipi-
tation of insoluble iron (III) (Crichton and Pierre, 2001). As a
result, almost all living organisms from archaea to eukaryotes
require iron in their metabolism. Borrelia burgdorferi is unique
among pathogens in that it bypassed iron dependence by substi-
tuting zinc or manganese for iron in its metalloproteins (Posey
and Gherardini, 2000; Nguyen et al., 2007).
Abbreviations: ACD, anaemia of chronic disease; β2m, beta-2-microglobulin;
DFO, desferrioxamine; HH, hereditary hemochromatosis; Lcn-2, Lipocalin 2;
MHC-I, major histocompatibility complex class I; NO, nitric oxide; NOS2, nitric
oxide synthase 2; ROS, reactive oxygen species.
IRON METABOLISM IN THE HOST
Vertebrates have evolved a complex network of proteins to
acquire, transport and store iron, while maintaining free iron
concentration at very low levels (reviewed in Kaplan and Ward,
2013). In mammals there is no regulated excretion of iron and
the replenishment of losses from desquamation and minor bleed-
ing, which account for the loss of less than 0.05% of body iron
per day, occurs at the level of intestinal absorption. Dietary iron,
either inorganic or bound to haem, is absorbed at the brush
border of enterocytes lining the proximal portion of the duo-
denum (Andrews and Schmidt, 2007). Iron is transported as
ferrous iron into circulation through ferroportin, the only cel-
lular iron exporter. Transferrin is the physiological carrier of
iron in plasma, binding two atoms of ferric iron. In humans,
the normal saturation of transferrin is only 20–40% (Ganz and
Nemeth, 2012b). Iron-loaded transferrin binds with high affin-
ity to the transferrin receptor (TFR)-1, ubiquitously expressed
at cell surfaces, and is internalized by clathrin-dependent endo-
cytosis. Iron is then released intracellularly and becomes part
of the labile iron pool (Correnti and Strong, 2012). Iron that
is not needed for immediate use or export is stored in ferritin.
In vertebrates, cytosolic ferritin is formed by the spontaneous
assembly of 24 subunits of Heavy (H) and Light (L) chains, result-
ing in a hollow shell capable of accommodating up to 4500 iron
atoms in an inert, non-toxic form (Harrison and Arosio, 1996).
Erythropoiesis is the most avid consumer of iron in the mam-
mal organism. Approximately 60–70% of the human adult body
iron is bound within haemoglobin (∼2.5 g). With the erythro-
cyte lifespan of 120 days, the reutilization of iron recycled from
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senescent cells accounts for most of the iron flux (Ganz and
Nemeth, 2012b). The hormone hepcidin is regarded as the central
regulator of systemic iron homeostasis. Hepcidin is a 25 amino
acid peptide that is mainly produced by hepatocytes. It binds
to the iron exporter ferroportin, causing its internalization and
degradation. Consequently, it reduces the absorption of dietary
iron by enterocytes and the release of iron from intracellular
stores (Ganz and Nemeth, 2012a).
As described, macrophages play a central role in regulating
iron metabolism since they recycle haem iron and regulate its
storage. However, since macrophages respond to other environ-
mental cues such as signals from the immune system, they may
undergo major and distinct physiological adaptations in differ-
ent settings namely those that are triggered by infection. For
example, it is known that classic activation of macrophages (M1
macrophages) e.g., by gamma interferon together with microbial
molecules acting as Toll-like receptor ligands modulates a dif-
ferent program of iron handling as compared to the alternative
activation (M2 macrophages) induced by cytokines such as inter-
leukin (IL)-4 and IL-13 induced in certain types of infection or
by cues from tissues in steady-state conditions (Recalcati et al.,
2012). The ensuing consequences at the systemic level are distinct
as classic activation promotes the sequestration of iron leading to
systemic lowering of its availability whereas alternative activation,
by promoting export of the metal by macrophages would lead to
the opposite systemic effects.
TRANSITION METALS DURING INFECTION
Successful colonization of a host by pathogens requires that these
must gain access to the required amounts of transition met-
als. Vertebrate hosts exploit this requirement by sequestering
these elements (Figure 1A). Iron withholding is the most well-
studied example of metal deprivation. A complex network of
host proteins renders this valuable nutrient largely inaccessible
to pathogens, a concept usually known as nutritional immunity
(Appelberg, 2006a; Hood and Skaar, 2012). However, recent evi-
dences suggest that this mechanism is also used to sequester other
transition metals, including manganese and zinc (Kehl-Fie and
Skaar, 2010). The strict requirement for transition metals is due
to their involvement in numerous processes ranging from micro-
bial metabolism to accessory virulence factor function. Hence,
without the required concentration of these nutrients, the invad-
ing agent is unable to proliferate and cause disease (Kehl-Fie and
Skaar, 2010).
The host can capitalize on the toxicity of transition met-
als and increase their concentration in the compartment where
pathogens proliferate (Figure 1B). By this mechanism, transition
metals can potentiate pathogen killing together with the respi-
ratory burst in phagocytes. The moderately reactive superoxide
radical is rapidly reduced to hydrogen peroxide, either sponta-
neously or enzymatically. In turn, hydrogen peroxide may give
rise to the highly reactive and short-lived hydroxyl radicals in the
Fenton reaction, by reacting with a reduced transition metal, such
as Fe(II) or Cu(I) (Galaris and Pantopoulos, 2008; Hodgkinson
and Petris, 2012), resulting in oxidative damage to the pathogen.
The toxicity of copper against M. tuberculosis has been reported
(Wolschendorf et al., 2011) and a copper-transporting ATPase
FIGURE 1 | Transition metals in immunity against intracellular
pathogens. Upon entry into the host cell, the pathogen is able to retrieve
metals from its surroundings to incorporate them in mettaloproteins strictly
required for its survival. The pathogen uses dedicated transporters and
specialized proteins [e.g., siderophores (Hider and Kong, 2010), high-affinity
iron chelating compounds] to acquire metals from the cytoplasmic pools or
by hijacking the cell pathways of metal acquisition (for example,
Mycobacterium and Leishmania have access to transferrin-bound iron in the
endocytic pathway). One of the countermeasures employed by the host
cell to reduce the proliferation of the pathogen is metal deprivation (A). This
is achieved by pumping out the metal from the phagosome, mediated by
metal transporters such as SLC11A1, which is recruited to the phagosomal
membrane, where it transports iron and manganese out of this
compartment. The metal can then be diverted into storage [e.g., the
iron-storage ferritin is induced during infection with Salmonella (Nairz et al.,
2007) and Mycobacterium (Silva-Gomes et al., 2013b)] or exported [e.g.,
ferroportin, an iron exporter that localizes to the cellular membrane, is
induced in macrophages infected with Mycobacterium (Van Zandt et al.,
2008) and Salmonella (Nairz et al., 2007)]. On the other hand, the host cell
can explore the toxicity of transition metal and direct them to the microbial
invader (B). During infection, metal transporters such as copper transport 1
(CTR1) (White et al., 2009) are induced, and transport the metal from the
extracellular environment. Metals are also mobilized from intracellular
storage [e.g., macrophages mobilize zinc from intracellular stores when
infected with M. tuberculosis or E. coli (Botella et al., 2011)], which will then
accumulate in the phagosome by the action of metal transporters, such as
the copper transporter ATP7A (White et al., 2009).
has been identified in macrophages (White et al., 2009). Other
mechanisms of metal intoxication independent of oxidative stress
have also been proposed. For example, it was suggested that metal
cofactor replacement may mediate copper toxicity against bacte-
ria (Rowland and Niederweis, 2012) and that perturbation of a
defined ratio of transition metals is detrimental to bacterial phys-
iology, which may underlie zinc and manganese toxicity (Botella
et al., 2011; Hood and Skaar, 2012).
This review focuses on the effect of availability of iron, the
most abundant transition metal in the vertebrate host, during
infection with two intracellular pathogens, Mycobacterium and
Leishmania.
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IRON METABOLISM INMycobacterium INFECTION
Tuberculosis remains the most important bacterial infection
worldwide. It is estimated that one third of the world popula-
tion is infected with M. tuberculosis. However, in 90% of the
cases immunity is able to prevent disease, leading in the major-
ity of cases to latent infection. The advent of the AIDS epidemic
and the introduction of immunosuppressive therapies dramat-
ically increased the number of people at risk of infection not
only with M. tuberculosis but also with other Mycobacterium
species that otherwise would not cause disease. This is the case of
Mycobacterium avium, a Non Tuberculous Mycobacteria (NTM).
Whereas M. tuberculosis is a primary pathogen, M. avium is sel-
dom identified as one. The twomycobacterial species differ in that
opportunistic infection by M. avium occurs in advanced stages of
AIDS when blood CD4+ T cell counts are lower than 50 per mm3,
whereas infection of AIDS patients withM. tuberculosis is not lim-
ited to such late stages of the disease.M. tuberculosis has no known
reservoir other than humans. The bacteria are almost exclusively
transmitted by aerosolized droplets, generated by the cough or
sneeze of a person with M. tuberculosis lung infection and are
inhaled by an uninfected person. In contrast, M. avium does
not seem to be transmitted between hosts and infection occurs
usually through tap water. Although mycobacteria can infect sev-
eral cell types (e.g., epithelial cells, eosinophils, neutrophils and
dendritic cells) the macrophage has long been established as the
central cell during the infection, being the primary player of cel-
lular immunity as well as the main site of bacterial replication.
Despite the differences that make M. tuberculosis a highly suc-
cessful pathogen and M. avium an opportunistic infectious agent
that mostly affects patients with compromised immunity, stud-
ies in the mouse model showed that immune response to both
mycobacteria is similar, namely regarding the pivotal roles of
CD4+ T cells, macrophages, and the IL12–IFNγ cytokine axis.
This is also the case of iron availability, as it will be discussed
below.
For a review regarding pathogenesis of infection withM. tuber-
culosis and M. avium we refer the readers to (Cooper, 2009) and
(Appelberg, 2006b), respectively.
HOST IRON STATE: EVIDENCES FROM HUMAN STUDIES
Iron availability can be a determinant factor during infections
withmycobacteria. In the nineteenth century, Armand Trousseau,
a French physician, already documented the dangers of giv-
ing iron to patients suffering from tuberculosis. He observed
that although tuberculosis patients developed some degree of
anaemia, iron supplementation in their diet resulted in a poorer
outcome than those patients who did not receive additional iron
(Trousseau, 1872). Contemporary studies have corroborated this
link between iron and tuberculosis. In 1996, Gordeuk et al. rean-
alyzed an autopsy study performed in South Africa in the 1920s,
and found a relationship between death from tuberculosis and
hepatic and splenic iron overload, notably with increased iron
deposition in the mononuclear macrophage system (Gordeuk
et al., 1996). Epidemiological studies in rural Zimbabwe have also
shown a correlation between iron overload induced by dietary
intake of iron (although genetic predisposition could also be a
factor), and the risk of active pulmonary tuberculosis (Gangaidzo
et al., 2001). Finally, a recent study has shown iron redistribution
to macrophages in HIV infected patients to be a risk factor for the
development of tuberculosis (McDermid et al., 2013).
Owing to the strict regulation of intestinal absorption, iron
overload of mammalian organisms is rare. However, certain
genetic diseases can lead to iron overload, such as heredi-
tary hemochromatosis (HH), the most common inherited sin-
gle gene disorder in people of Northern and Western Europe.
This disease is most often associated with mutations in a
molecule, HFE, homologous to class I major histocompatibil-
ity complex (MHC) alpha chains. These patients spontaneously
develop hepatic iron overload, with iron accumulation in hep-
atocytes but not in macrophages. Given the reduced capac-
ity of the macrophage to retain iron, human macrophages
from HH patients where shown to be less permissive to M.
tuberculosis growth (Olakanmi et al., 2007). However, whether
this is true at an all-organism level is not known, as epi-
demiologic data from the incidence of tuberculosis in HH
patients are not available. Furthermore, results from mouse
models of HH indicated that the overall tissue iron over-
load contributes to susceptibility to mycobacteria (discussed
below).
HOST IRON STATE: EVIDENCES FROM THE MOUSE MODEL
For the most part, the findings in humans described above have
been very effectively reproduced in the mouse model of experi-
mental infections with mycobacteria.
Our group has shown that an iron poor diet led to a reduced
proliferation ofM. avium in mice (Gomes et al., 1999a), while the
parenteral administration of iron-dextran led to an increased pro-
liferation of the bacilli (Gomes and Appelberg, 1998; Gomes et al.,
2001). Likewise, others have shown that either the parenteral
overload of iron in the form of polymaltose ferric hydroxide
(Lounis et al., 1999, 2001) (Lounis et al., 2003) or the admin-
istration of iron citrate through the drinking water (Schaible
et al., 2002) rendered the mice more susceptible to experimental
infection with M. tuberculosis.
Mice deficient in HFE or in the HFE-binding protein beta-
2-microglobulin (β2m−/−) spontaneously develop hepatic iron
overload, similar to HH patients (De Sousa et al., 1994; Zhou
et al., 1998). β2m−/− mice are known for a long time to be
more susceptible to M. tuberculosis, an effect initially attributed
to a lack of major histocompatibility complex class I (MHC-I)
restricted cells (Flynn et al., 1992). However, MHC-I-KO animals
are less susceptible to M. tuberculosis than β2m−/− mice (Rolph
et al., 2001; Schaible et al., 2002). Schaible et al. have shown that
correcting the iron overload in these mice, through the adminis-
tration of lactoferrin, reduced their mycobacterial loads to levels
comparable to MHC-I-KO animals, proving that iron availability
is the major factor accounting for the increased susceptibility of
β2m−/− mice to experimental tuberculosis (Schaible et al., 2002).
In our group, we also found that the increased accumulation of
iron in β2m−/− mice is associated with an increased suscepti-
bility to M. avium experimental infection (Gomes-Pereira et al.,
2008). Furthermore, we showed a similar effect in HFE−/− mice
(Gomes-Pereira et al., 2008). Interestingly, although these models
of iron overload tend to accumulate iron in hepatocytes and not
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in macrophages, we observed that during infection iron accumu-
lates in macrophages within granulomas (Gomes-Pereira et al.,
2008).
THE FIGHT FOR IRON
In order to successfully establish an infection, mycobacteria must
gain access to iron and have therefore evolved strategies to acquire
iron from the host. Mycobacteria are able to block phagoso-
mal maturation, replicating in an intracellular compartment with
access to iron-loaded transferrin (Clemens and Horwitz, 1996;
Halaas et al., 2010). Interestingly, the ability of M. avium to pre-
vent phagosome maturation was shown to be dependent on its
capacity to acquire iron (Kelley and Schorey, 2003). In addi-
tion to transferrin, M. tuberculosis was also shown to be able
to acquire iron from lactoferrin (Olakanmi et al., 2004) and
from the macrophage cytoplasmic iron pools (Olakanmi et al.,
2002). Furthermore, M. tuberculosis can use haem as an iron
source (Jones and Niederweis, 2011; Tullius et al., 2011; Nambu
et al., 2013). In line with the notion that access to iron is a
requisite to cause a persistent infection, it was reported, using X-
ray microscopy, that iron concentration increased over time in
the phagosomes of macrophages infected with M. avium or M.
tuberculosis, while it decreased in those infected with the non-
pathogenic M. smegmatis (Wagner et al., 2005). Several bacteria
are able to produce siderophores, lowmolecular weight molecules
with high affinity for iron. Pathogenic mycobacteria, such as M.
tuberculosis and M. avium, synthetize siderophores that remain
associated to the cell wall, termed mycobactins, and others that
are secreted, named carboxymycobactins (Ratledge, 2004). These
siderophores are able to remove iron from host iron-binding pro-
teins, such as transferrin and lactoferrin (Gobin and Horwitz,
1996). In M. tuberculosis a gene cluster that encompasses 10
genes, designated mbtA-J, encodes the machinery responsible for
siderophore biogenesis (Quadri et al., 1998).mbtB (De Voss et al.,
2000), mbtD (Jones and Niederweis, 2011), and mbtE (Reddy
et al., 2013) mutants show restricted growth in iron-deficient
medium and in macrophages, suggesting that siderophore syn-
thesis is required for M. tuberculosis virulence. Indeed, guinea
pigs infected with the mtbE mutant exhibited reduced bacillary
load in comparison with animals infected with the parental strain
(Reddy et al., 2013). However, these latter data should be con-
firmed since this study showed that the mutant strain induced
the same amount of moderate pathology in the lung as the wild
type strain despite its virtually complete elimination by 4 weeks of
infection. Whether that was due to the high inoculum used and
the persistence of inflammatory material from the mycobacteria
or to an underestimation of the bacterial loads given the difficul-
ties in growing the mutant strain in vitro is unclear. Noteworthy,
whereas pathology subsequently exacerbated in the hosts infected
with the wild type strain, it did not in animals infected with
the mutant strain. In addition to the synthesis of siderophores,
proteins involved in their import or export are also critical for vir-
ulence. IrtAB, a transporter of iron-loaded carboxymycobactin,
is required for the replication of M. tuberculosis in macrophages
and in vivo in a mouse model of aerosol infection (Rodriguez
and Smith, 2006). A siderophore export system was recently
identified in M. tuberculosis, involving the proteins MmpS4 and
Mmsp5 (Wells et al., 2013). Deletion of both mmpS4 and mmpS5
drastically decreases synthesis and secretion of siderophores and
notably reduces M. tuberculosis virulence in mice (Wells et al.,
2013).
The essentiality of iron acquisition systems for mycobacte-
rial survival has led to the suggestion that this pathway could
constitute a new drug target in anti-mycobacteria drug devel-
opment (Appelberg, 2006a; Meyer, 2006). In fact, several com-
pounds with the capacity to interfere with siderophore synthesis
and/or function were shown to have strong inhibitory activity
against M. tuberculosis (Ferreras et al., 2005, 2011). It should
be noted that although some compounds that interfere with
siderophore synthesis showed promising results in axenic cul-
tures of M. tuberculosis (Ferreras et al., 2005), their effect in a
mouse model of M. tuberculosis infection is very limited (Lun
et al., 2013). These observations may indicate that (1) mycobac-
teria have access in vivo to others forms of iron independent of
siderophore acquisition [e.g., haem iron (Jones and Niederweis,
2011)] or (2) the compound is not reaching the cells harboring
mycobacteria. Alternative possible targets for new drug devel-
opment may instead include the siderophore transport systems.
We have also shown that the addition of iron chelators to M.
avium cultures, either in axenic culture, in macrophage cultures,
or in vivo led to significant decreases in mycobacterial growth
(Gomes et al., 1999a; Fernandes et al., 2010). Furthermore,
we have developed new molecules based on the 3-hydroxy-4-
pyridinone iron chelating moiety, in which the inclusion of a rho-
damine residue improved anti-mycobacterial activity, presumably
through improved intracellular distribution and targeting for
the mycobacteria-containing phagosome (Fernandes et al., 2010;
Nunes et al., 2010; Moniz et al., 2013).
During an infection, the host uses several mechanisms to
withhold iron access from pathogens. Anaemia often develops
during acute or chronic infections, which is known as anaemia of
chronic disease (ACD), and is thought to represent a mechanism
to limit iron availability to the invading microorganisms (Weiss,
2009). ACD, the second most common type of anaemia (after
anaemia of iron-deficiency) is characterized by hypoferremia (low
serum iron) and increased iron retention within the mononu-
clear phagocyte system (Roy, 2010). Anaemia was described in the
mouse model of infection with M. avium (Rodrigues et al., 2011)
and M. bovis BCG (Marchal and Milon, 1981), and epidemi-
ologic studies showed that tuberculosis is frequently associated
with anaemia (Lee et al., 2006; Sahiratmadja et al., 2007). One of
the putative links between immunity and the anaemia is hepcidin,
a peptide that regulates iron homeostasis by mediating the degra-
dation of ferroportin, an iron exporter protein. In vitro, infection
of macrophages with M. avium and M. tuberculosis induce the
hepcidin mRNA expression (Sow et al., 2007). However, using a
microarray platform to analyse the iron-related genes regulated
by M. avium infection, we did not find hepcidin to be induced in
the liver (Rodrigues et al., 2011), questioning the role of hepcidin
in the development of anaemia during mycobacterial infections.
Nevertheless, hepcidin produced by infected macrophages may
have a local effect, rather than a major role in the systemic iron
regulation. Indeed, Sow et al. (2007) showed that hepcidin local-
izes to the mycobacteria-containing phagosomes and possesses
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direct antimicrobial activity againstM. tuberculosis, causing struc-
tural damage to the mycobacteria. How anaemia develops in the
context of mycobacterial infection remains to be determined.
Anaemia independent of the expression of hepcidin has been
observed in other situations, namely after LPS administration to
TIR domain-containing adaptor protein (TRIF)-deficient mice
(Layoun et al., 2012) and Hepcidin+/− mice (Deschemin and
Vaulont, 2013), in a murine model of protracted peritonitis
(Schubert et al., 2012) and notably following TNF administration
to mice (Laftah et al., 2006).
There is experimental evidence that some degree of haemol-
ysis and release of free haem may occur during severe infection
(Larsen et al., 2010). Free haem contributes to an increased sus-
ceptibility to mycobacterial infection, most likely involving mech-
anisms that differ from those associated to other forms of iron,
and haem-oxygenase-1, the enzyme responsible for haem detox-
ification is essential for host protection against these infections
(Silva-Gomes et al., 2013a).
One of the ways by which the host can interfere with the
pathogen acquisition of iron is through the action of lipocalin
(Lcn)-2. Lcn-2, also known as siderocalin, neutrophil gelatinase-
associated lipocalin (NGAL) or 24p3, is capable of binding
siderophores (Goetz et al., 2002) and transport them into cells
by endocytosis, after interacting with a specific cell-surface recep-
tor (Devireddy et al., 2005). Lcn-2 is able to bind carboxymy-
cobactin from mycobacteria (Holmes et al., 2005) and inhibit
the growth of M. tuberculosis and M. bovis BCG in liquid cul-
ture, in a dose-dependent manner reversible by the addition
of iron or recombinant carboxymycobactin (Saiga et al., 2008).
Furthermore, Lcn-2-deficient mice are highly susceptible to intra-
tracheal infection withM. tuberculosis (Saiga et al., 2008). Of note,
recent studies have shown that Lcn-2 can also function as an iron
shuttle in basal metabolism of the host, either delivering iron to
or stealing iron from specific cell types, implicating Lcn-2 in pro-
cesses unrelated to its function in immunity (Correnti and Strong,
2012).
Inside infected macrophages, pathogen’s access to iron may be
limited by SLC11A1. SLC11A1 is a divalent metal transporter,
recruited to the late endosomal and phagosomal membrane
of macrophages and other professional phagocytes (Nevo and
Nelson, 2006). Although SLC11A1 contributes to macrophages’
efficiency in the recycling of erythrocyte-derived iron (Soe-Lin
et al., 2009), the main function of SLC11A1 seems to be the pro-
tection against microbes. The Slc11a1 gene is present in inbred
strains of mice in two allelic forms which determine the resis-
tance or susceptibility to several intracellular pathogens such as
Mycobacterium spp., Salmonella spp and Leishmania spp (Vidal
et al., 1993). Susceptible mice carry a glycine (G) to aspartic
acid (D) substitution at position 169, resulting in a misfolding
and loss of function of the protein (White et al., 2004). This
mutation confers susceptibility to several mycobacterial species,
such as M. avium (Appelberg and Sarmento, 1990; Gomes and
Appelberg, 1998), M. intracellulare (Goto et al., 1989), M. bovis
BCG (Gros et al., 1981) but not to M. tuberculosis (Medina and
North, 1996; North et al., 1999). Although the G169D muta-
tion has never been found in humans, polymorphic variations
at or near human SLC11A1 are associated with susceptibility to
tuberculosis and leprosy in populations from areas of endemic
disease (Fortier et al., 2005). The directionality of metal transport
in the SLC11A1 is still not consensual. Some groups suggest that
iron is transported via this protein into the pathogen-containing
phagosome, causing the death of the pathogen by catalyzing the
formation of reactive oxygen species (ROS) (Kuhn et al., 1999,
2001; Zwilling et al., 1999), while others argue for an iron efflux
from the phagosome, restricting pathogen growth by iron depri-
vation (Gomes and Appelberg, 1998; Mulero et al., 2002). Studies
of analogy with DMT1 (NRAMP2) (Forbes and Gros, 2003), the
resistance of mycobacteria to ROS (Segal et al., 1999; Gomes and
Appelberg, 2002) and the role of SLC11A1 in erythrocyte recy-
cling (Soe-Lin et al., 2009) favor the second hypothesis, which
is now seen as more consensual in the literature (Schaible and
Kaufmann, 2004; Cellier et al., 2007; Wessling-Resnick, 2010).
Another iron transporter expressed in macrophages is fer-
roportin (SLC40A1). Ferroportin is present in the macrophage
cytoplasmic membrane and is responsible for iron export
(Knutson et al., 2005). Overexpression of ferroportin was
reported to inhibit the intra-macrophagic growth of M. tuber-
culosis presumably through iron deprivation (Johnson et al.,
2010). An interplay between the expression of ferroportin
and the activation of the macrophage’s inducible nitric oxide
synthase (NOS2) seems to occur. While the overexpression
of ferroportin decreased macrophages nitric oxide produc-
tion (Johnson et al., 2010), the expression of NOS2 was
reported by Nairz et al to be necessary to maintain ferro-
portin expression and iron efflux (Nairz et al., 2013). In this
study, Salmonella residing within nitric oxide synthase defi-
cient (Nos2−/−) macrophages acquired more iron than bacte-
ria within wild-type macrophages and the authors concluded
that iron deprivation is the main way through which NOS2
contributes to Salmonella control. However, while M. avium
depends on access to iron to proliferate inside macrophages,
Nos2−/− macrophages and mice are not more permissive to the
growth of this mycobacterium (Gomes et al., 1999b), suggest-
ing that the mechanism for the regulation of iron availability
by NO during Salmonella infection does not apply to M. avium
infections.
IRON METABOLISM IN Leishmania INFECTION
The leishmaniases are a complex of mammalian diseases char-
acterized by distinct clinical manifestations: cutaneous, muco-
cutaneous and visceral leishmaniasis. Though considered to be
neglected tropical diseases, their global incidence is a worri-
some 2 million new cases per year. They are caused by protozoa
of the genus Leishmania, whose transmission occurs through
the bite of female sandfly. Transmission mediated by the insect
may be zoonotic—between reservoir hosts (rodents and canines)
and humans—or anthroponotic (Ready, 2010). Disease is not
necessarily the final outcome in endemic areas where humans
stably share the habitat with wild rodents, dogs and the sand fly
populations as asymptomatic infections may occur.
Leishmania parasites have a digenetic life cycle, alternat-
ing between the promastigote stage in the insect gut and the
amastigote stage in macrophages of mammalian hosts. Although
Leishmania can infect diverse host cells (e.g., dendritic cells and
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neutrophils), there is only evidence for replication and long-term
survival within mononuclear phagocytes (Kaye and Scott, 2011).
HOST IRON STATE: EVIDENCES FROM HUMAN AND CANINE STUDIES
A direct link between host iron status and human or canine
susceptibility to Leishmania infection is not clearly found from
available epidemiologic data. The fact that several studies found
an association between susceptibility to leishmaniasis and poly-
morphisms in the SLC11A1 gene, which codes for a transmem-
brane transporter of iron and other divalent metals, as mentioned
before (Altet et al., 2002; Bucheton et al., 2003; Sanchez-Robert
et al., 2008; Blackwell et al., 2009; Castellucci et al., 2010) and,
on the other hand, the generalized association between leishma-
niasis and malnutrition (Maciel et al., 2008; McCall et al., 2013)
are indirect evidences that the host iron status may influence the
outcome of the Leishmania infection. However, more direct cor-
relations can only be made based on the studies performed in
several infection models.
HOST IRON STATE: EVIDENCES FROM RODENT MODELS
Despite the lack of direct clinical evidences, we could expect iron
to favor the growth of Leishmania, similarly to what is found for
other pathogens (Weinberg, 2009). The fact that these parasites
are equipped with diverse iron acquisition mechanisms and are
capable of utilizing various iron sources suggested that iron acqui-
sition was essential for pathogenicity and that iron deprivation
could be an effective strategy to control leishmanial infections
(Sutak et al., 2008; Taylor and Kelly, 2010). Such hypothesis is
supported by the finding that the iron chelators desferrioxam-
ine (DFO) and hydroxypyridin-4-ones moderately inhibit the
multiplication of L. major and L. infantum promastigotes in cul-
ture medium (Soteriadou et al., 1995). However, DFO has shown
either no effect (Murray et al., 1991) or an inhibitory effect on the
intramacrophagic growth of L. donovani (Segovia et al., 1989; Das
et al., 2009) and L. amazonensis (Borges et al., 1998). Moreover,
treatment of mice with DFO does not affect the development of
skin lesions caused by L. major (Bisti et al., 2000), but reduces
the hepatic and splenic growth of L. infantum (Malafaia et al.,
2011). Conversely, feeding mice with an iron-deficient diet did
not influence L. infantum proliferation (Vale-Costa et al., 2013).
Overall, the existing studies do not thoroughly support the notion
that iron depletion contributes to the control of leishmanial
infections.
Data obtained in cellulo concerning the impact of iron supple-
mentation is also not consensual. Iron treatment either favored
the intramacrophagic growth of L. donovani (Das et al., 2009)
and L. amazonensis (Borges et al., 1998) and reversed the capac-
ity of activated macrophages to eliminate L. enriettii (Mauel et al.,
1991) or had no influence on both effects (Murray et al., 1991).
Interestingly, the role of this nutrient on the in vivo growth of
the parasite seems to be dependent on the host species. Iron
given to hamsters prophylactically or therapeutically enhanced
L. donovani replication (Garg et al., 2004). By contrast, in vivo
iron administration to susceptible mice clearly leads to contain-
ment of L. major in the skin (Bisti et al., 2000, 2006; Bisti and
Soteriadou, 2006) and L. infantum in the liver and spleen (Vale-
Costa et al., 2013). The anti-leishmanial effect of iron is most
likely due to its synergistic interaction with reactive oxygen and
nitrogen species produced by the host’s professional phagocytes
(Bisti et al., 2006; Vale-Costa et al., 2013). Furthermore, the con-
trol of L. major infection, but not that of L. infantum, by iron
also correlates with the development of a T helper 1 (Th1)-type
immune response (Bisti et al., 2000), which is characterized by
(i) an increased ability of splenic cells to present L. major-derived
peptides, (ii) increased levels of IFNγ and NOS2 and decreased
levels of IL-4 and IL-10 transcripts at the lesion site and (iii)
reduced levels of serum immunoglobulin (Ig) E and IgG1 and
increased levels of IgG2a (Bisti et al., 2000). Notably, iron over-
loaded mice are also resistant to re-infection with L. major (Bisti
and Soteriadou, 2006). The iron-induced oxidative burst elicited
during both primary and secondary infections with L. major is
linked to the activation of the transcription factor NF-κB andwith
an enhanced proliferation of IFNγ-secreting CD4+ T cells in the
draining lymph nodes (Bisti and Soteriadou, 2006). This is sub-
stantiated by the fact that iron and reactive oxygen and nitrogen
species can modulate the activation of macrophagic NF-κB sig-
naling pathways (Xiong et al., 2003; Leonard et al., 2004; Galaris
and Pantopoulos, 2008) which are known to regulate numerous
genes involved in immune and inflammatory responses (Bonizzi
and Karin, 2004). Indeed, NF-κB regulates the development of
IFNγ-secreting CD4+ T cells and concomitant resistance to L.
major (Artis et al., 2003). Hence, iron not only seems to synergize
with the host’s oxidative mechanisms of defense, but also inter-
acts with reactive oxygen and nitrogen species in order to activate
signaling cascades that regulate the development of protective
immunity against Leishmania.
The abovementioned reports clearly indicate that iron induces
host protection against Leishmania infection. Future research
should seek a confirmation of the inhibitory effect of iron on the
in vivo growth of other Leishmania species and a better under-
standing of the molecular pathways involved in the iron-induced
resistance against these protozoa.
THE FIGHT FOR IRON
Like many other intracellular pathogens, Leishmania must be
capable of acquiring iron from the host milieu in order to thrive.
Besides holotransferrin (Borges et al., 1998), the growth and sur-
vival of L. infantum and L. amazonensis amastigotes can be sup-
ported by iron derived from haemoglobin and hemin (Carvalho
et al., 2009). The uptake of haem by intramacrophagic L. ama-
zonensis amastigotes is mediated by Leishmania haem response 1
(LHR1) protein (Huynh et al., 2012). Furthermore, intracellular
L. amazonensis also possesses a ferric reductase, the Leishmania
ferric iron reductase 1 (LFR1) (Flannery et al., 2011) which
provides soluble ferrous iron for transport across the parasite
plasma membrane by the ferrous iron transporter Leishmania
iron transporter 1 (LIT1) (Huynh et al., 2006; Jacques et al., 2010).
Moreover, LIT1-mediated iron acquisition seems to be essential
for the differentiation of L. amazonensis parasites from the sandfly
promastigote form to the macrophage-adapted amastigote form
(Mittra et al., 2013).
Apart from the mechanisms of direct iron internalization,
Leishmania parasites can also subvert the host’s iron uptake sys-
tems to their own advantage. In fact, L. amazonensis amastigotes
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can obtain transferrin by forcing the fusion of transferrin-
containing endosomes with the parasitophorous vacuole (Borges
et al., 1998). Alternatively, L. donovani is capable of decreasing the
macrophage labile iron pool, a process that triggers an increased
surface expression of transferrin receptor 1 and internalization
of transferrin, thus permitting a continuous provision of iron to
the parasite (Das et al., 2009). This decrease in labile iron pool
of activated macrophages has been recently proposed to be the
result of the down-regulation of the expression of SLC11A1 by a
L. donovani-secreted peroxidase (Singh et al., 2013). Also in line
with these data, it has been reported that the expression of fer-
roportin is down-regulated in the spleen of L. donovani-infected
mice, which may contribute to an increased accumulation of iron
inside macrophages (Yang et al., 2002).
The existence of a parasitic strategy to counteract host
SLC11A1 action reinforces the involvement of the latter in the
in vivo control of infection by Leishmania (Vidal et al., 1995;
Searle et al., 1998; White et al., 2005), as mentioned previously.
This protein has also been implicated in the response to vacci-
nation. Mice with functional SLC11A1 mount primarily a Th1
response to vaccination with the parasite metalloprotease Gp63
and display decreased skin lesions during a challenge infection
with L. major. In striking contrast, mice with mutated SLC11A1
exhibit a Th2 response and an exacerbated lesion growth upon
challenge (Soo et al., 1998).
Finally, we should acknowledge that the involvement of other
host mechanisms of iron deprivation during leishmanial infec-
tions is largely unknown.
IRON DEPRIVATION vs. IRON-INDUCED TOXICITY
As the number of antibiotic resistant pathogens increases and the
discovery of new antibiotics declines, the understanding of criti-
cal pathways in host-pathogen interaction emerges as a promising
source of new approaches to fight infections. The modulation of
iron availability may be one of such pathways. However, it should
be noted that the choice of whether to provide or to deprive
the pathogen of iron clearly depends on the microorganism in
question.
The first widely used treatments for leishmaniasis relied on
the administration of antimony complexes. Not excluding other
possible mechanisms of action, strong evidences suggest that anti-
mony compounds kill Leishmania parasites through the increased
generation of ROS in the host (Ait-Oudhia et al., 2011) similarly
to what we and others recently described for iron (Bisti et al.,
2006; Vale-Costa et al., 2013). Of interest, other metal-containing
drugs continue to be described as potential new therapies against
Leishmania (Vale-Costa et al., 2012; Rocha et al., 2013). The main
concern raised by these metal-providing tools is obviously the
inherent toxicity of the metals associated with their propensity
to induce oxidative stress. One of the possible ways to circumvent
this problem will be to use new specific delivery systems to target
the drug to infected macrophages.
In the case of mycobacterial infections, it is well-established
that iron deprivation inhibits pathogen proliferation and iron
depriving strategies seem the most promising in therapeutic
terms. However, the administration of iron chelators is not
exempt from risks to the host, especially in a context where the
latter activates a series of iron withholding mechanisms which
may lead to anaemia. The findings of the last decade on the
players that control host iron metabolism, notably the identifica-
tion of the iron exporter ferroportin and the hormone hepcidin,
have opened new and exciting possibilities for the modulation of
iron availability and localization inside cells which should provide
ways of specifically depriving intracellular pathogens, without
hampering the normal iron homeostasis of the host.
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